Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1FUZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,179
Award facts
- Contract value 100% obligated
- $55,178.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $55,178.96 delivery order to AmerisourceBergen Drug Corp for KESIMPTA 20 mg/0.4 mL pen auto-injectors on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor vehicle running through December 2026. The place of performance is listed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
KESIMPTA (ofatumumab) is a monoclonal antibody treatment used in multiple sclerosis management, representing the specialized pharmaceutical products AmerisourceBergen supplies through its extensive portfolio of federal contracts with the Defense Logistics Agency and other government healthcare systems. This delivery order exemplifies the company's role as a critical vendor for military and veteran healthcare systems, fulfilling federal medical supply requirements across therapeutic domains including specialty medications, biologics, and auto-injector delivery systems. As a non-set-aside award, this contract was competitively procured, demonstrating AmerisourceBergen's continued capability to meet stringent federal procurement standards for pharmaceutical distribution.
Quick answers
Who was awarded contract SPE2DR26F1FUZ?
SPE2DR26F1FUZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F1FUZ worth?
The government has obligated $55,179 on SPE2DR26F1FUZ.
Is contract SPE2DR26F1FUZ an order under another contract?
Yes. SPE2DR26F1FUZ is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1FUZ competed?
The extent of competition for SPE2DR26F1FUZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award